Экспериментальная и клиническая фармакология(2014)
被引用0|浏览0
摘要
The neuroprotective properties of the novel glutamic acid derivative neiroglutam have been studied in vitro and in vivo . Neiroglutam demonstrated the protective action on 6-OH-dopamine neurotoxicity model in vitro , where free radical oxidation is a basic part of pathogenesis. In control rats, focal brain ischemia caused significant increase in thiobarbituric acid reactive species (TBARS) level and decrease in superoxide dismutase (SOD) enzyme activity. In two-year-old rats, preventive administration of the neiroglutam caused a significant reduction in the TBARS plasma concentration (34.5%, p < 0.05), increased SOD activity, and increased the time of acid-induced hemolysis of erythrocytes (40%, p < 0.05).